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Abstract
Background: Global responses to the COVID-19 pandemic have exposed and exacerbated existing socioeconomic
and health inequities that disproportionately affect the sexual health and well-being of many populations, including
people of color, ethnic minority groups, women, and sexual and gender minority populations. Although there have
been several reviews published on COVID-19 and health disparities across various populations, none has focused on
sexual health. We plan to conduct a scoping review that seeks to fill several of the gaps in the current knowledge
of sexual health in the COVID-19 era.
Methods: A scoping review focusing on sexual health and COVID-19 will be conducted. We will search (from
January 2020 onwards) CINAHL, Africa-Wide Information, Web of Science Core Collection, Embase, Gender Studies
Database, Gender Watch, Global Health, WHO Global Literature on Coronavirus Disease Database, WHO Global
Index Medicus, PsycINFO, MEDLINE, and Sociological Abstracts. Grey literature will be identified using Disaster Lit,
Google Scholar, governmental websites, and clinical trials registries (e.g., ClinicalTrial.gov, World Health Organization,
International Clinical Trials Registry Platform, and International Standard Randomized Controlled Trial Number
Registry). Study selection will conform to the Joanna Briggs Institute Reviewers’ Manual 2015 Methodology for JBI
Scoping Reviews. Only English language, original studies will be considered for inclusion. Two reviewers will
independently screen all citations, full-text articles, and abstract data. A narrative summary of findings will be
conducted. Data analysis will involve quantitative (e.g., frequencies) and qualitative (e.g., content and thematic
analysis) methods.
Discussion: Original research is urgently needed to mitigate the risks of COVID-19 on sexual health. The planned
scoping review will help to address this gap.
Systematic review registrations: Systematic Review Registration: Open Science Framework osf/io/PRX8E
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Background
Global responses to the COVID-19 pandemic have ex-
posed and exacerbated existing socioeconomic and
health inequities that disproportionately affect the health
and well-being of people of color, ethnic minority
groups, women, and sexual and gender minority popula-
tions [1–3]. Many sub-populations may experience
worse sexual health during COVID-19. Sexual health re-
search, broadly defined, is the study of an individuals’
physical, emotional, mental, and social well-being in re-
lation to sexuality; it goes beyond the absence of disease,
dysfunction, or infirmity [4]. In this respect, sexual
health has psycho-social dimensions, in addition to
physical dimensions. Sexual health research includes
studies that center on sexual minorities as a population
and comprises sexual behavior and access to high-
quality sexual health care. For the purposes of the
planned review, due to a lack of research and that sys-
tematic reviews on these areas are currently being con-
ducted, reproductive health, intimate partner violence,
and gender-based violence will not be considered com-
ponents of sexual health. Guidelines to stay at home, the
resulting economic impact on individuals and families,
and the need to shift healthcare resources (including
money, clinic space, and staff) to the COVID-19 re-
sponse are likely to affect sexual behavior, sexual health,
and access to quality sexual health care. Research sug-
gests that a reduction in economic opportunities may
impact sexual healthcare access for women [5]. Similarly,
during health crises, sexual health resources may be
diverted to the pandemic response, with the potential to
increase maternal mortality and limit abortion care and
contraception access [6, 7]. Sex workers worldwide may
see clients in person, risking infection and perhaps not
seeking medical care due to reduced healthcare
provision [8]. In some countries, like the USA, the
LGBTQIA community is also less likely to have health
insurance [9], increasing negative economic impacts if
they contract COVID-19. These factors may widen
socioeconomic inequity and further reduce access to
sexual health services. Key populations experience
unique challenges in the wake of the pandemic in-
cluding delays in seeking treatment due to fear of
stigma, discrimination, and involuntary outing of sex-
ual orientation or immigration status through contact
tracing and isolation [10].
Several published reviews have focused on COVID-19
and health outcomes across various populations [11, 12].
However, these reviews did not center on sexual health,
an area of health and well-being potentially negatively
affected by the pandemic. Sexual health is key to overall
human health and well-being and to the socioeconomic
development of communities and countries [13]. More-
over, people of color, women, and ethnic and sexual
minorities likely face greater negative impacts from the
pandemic, especially sexual health. The planned scoping
review seeks to compile published evidence in the field
to identify gaps in the current understanding of sexual
health and COVID-19. We will conduct a scoping review
rather than use other methods of research synthesis be-
cause scoping reviews are appropriate for mapping an
area of research [14]; we will not be examining the effect
of an intervention on an outcome of interest, and thus,
it does not make sense to assess the risk of bias, as per a
systematic review; and sexual health research outcomes
are likely not sufficiently similar to each other to warrant
pooling or formal meta-analysis regarding a specific out-
come. The review will include and contrast research de-
tailing sexual health and COVID-19 among individuals
of all genders and sexual identities [4]. This review will
also include research that has examined a broad range of
outcomes and studies related to sexual health and well-
being (e.g., testing, risk behaviors, treatment, PrEP use,
vaccination, gender-based violence, selling sex).
The planned scoping review will build on existing re-
views around COVID-19 and a range of other popula-
tions and health outcomes. Our review will chart the
change in sexual health research, such as shifts in topics
of focus and research technique (e.g., qualitative versus
quantitative), to determine if some research areas are
tied to changes in pandemic progression. Key to the de-
velopment of interventions that improve sexual health
amid COVID-19 is a comprehensive understanding of
the current status of evidence around sexual health dur-
ing the COVID-19 era. The planned scoping review
seeks to understand the gaps in the current knowledge
base on sexual health and COVID-19, especially in mar-
ginalized group such as sexual minorities and people liv-
ing with HIV. The planned scoping review seeks to
provide this evidence by contributing an evaluation of
available literature about sexual health in relation to
COVID-19, with the goal of identifying gaps in research.
Methods/design
The review protocol has been registered within the
Open Science Framework database (osf/io/PRX8E) and
is being reported in accordance with the reporting guid-
ance provided in the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses Protocols (PRIS
MA-P) statement [15] (see checklist in Additional file 1).
The proposed scoping review will be reported in accord-
ance with the reporting guidance provided in the Pre-
ferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) extension for Scoping Reviews
(PRISMA-ScR) [16]. Research objectives, inclusion cri-
teria, and methodological techniques will be determined
before study commencement using the Joanna Briggs In-
stitute Reviewers’ Manual 2015 Methodology for JBI
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Scoping Reviews [17]. This process will adhere to the in-
dicated framework: (1) identifying research question, (2)
developing comprehensive search strategy, (3) identify-
ing relevant studies, (4) selecting studies, (5) charting
data, and (6) collating, summarizing, and reporting re-
sults. The study team will develop a search strategy as
recommended by the 2015 Methodology for JBI Scoping
Reviews.
This scoping review will be conducted by 13 individ-
uals: 12 researchers from several universities worldwide,
from a range of disciplines (e.g., medicine, sociology,
demography, public health, criminology, economics,
psychology, epidemiology), and an informationist from
the Harvey Cushing/John Hay Whitney Medical Library
at Yale University. The objective of the scoping review is
to develop a better understanding of the current re-
search landscape around sexual health and COVID-19
by investigating the existing studies and gaps in the re-
search. The broad research questions are “what has been
reported on sexual health in the COVID-19 era?” and
“what are the gaps in the current knowledge base on
sexual health and COVID-19 across diverse populations,
including marginalized groups?” The search strategy will
be performed in line with techniques that enhance
methodological transparency and improve the reprodu-
cibility of the results and evidence synthesis.
Information sources and search strategy
The primary source of literature will be a structured
search of electronic databases (from January 2020 on-
wards): MEDLINE, EMBASE, CINAHL, PsycINFO, Web
of Science Core Collection, Africa-Wide Information,
Gender Studies Database, Gender Watch, Global Health,
WHO Global Literature on Coronavirus Disease Data-
base, WHO Global Index Medicus, and Sociological Ab-
stracts. The secondary source of potentially relevant
material will be a search of preprint servers (e.g.,
medRxiv.org, PsyArXiv.org), Disaster Lit, Google Scholar
(e.g., the first five pages will be searched), governmental
websites, and clinical trials registries (e.g., ClinicalTrial.
gov, World Health Organization International Clinical
Trials Registry Platform, and International Standard
Randomized Controlled Trial Number Registry). The
references of included documents will be hand-searched
to identify any additional evidence sources. The search
strategy will be designed by a research librarian and
peer-reviewed by using the Peer Review of Electronic
Search Strategies (PRESS) checklist [18]. A draft search
strategy for MEDLINE is provided in Additional file 2.
We will use search terms similar to our main search to
find articles for inclusion.
The same keywords for the main search will be used
to search grey literature each time. All grey literature
will be compiled in a folder and reviewed similarly to
articles obtained from our database searches. EndNote, a
bibliographic software, will be used to store, organize,
and manage all references [19].
Eligibility criteria
We will include all studies with all study designs in-
volving COVID-19 and sexual health. Only English
language studies will be considered for inclusion. Past
work indicated that excluding non-English language
records from a review seemed to have a minimal ef-
fect on the results [20, 21].
Inclusion criteria
Published research (peer-reviewed and grey literature
where primary data was collected such as reports, re-
search letters, and briefs) investigating sexual health and
COVID-19 in all populations, settings, and study de-
signs, e.g., studies with small samples, quantitative and
qualitative studies, will be eligible for inclusion. We will
include studies focusing on sex workers, LBTQIA per-
sons, and persons at risk for HIV, even if these studies
do not examine sexual health specifically. Primary out-
comes will include how the COVID-19 pandemic affects
sexual health, both effects of the lockdown and the bio-
logical impact of the virus on sexual health, and how the
COVID-19 pandemic affects sexual minorities. Primary
outcomes will not include reproductive health, intimate
partner violence, and gender-based violence alone.
There will be no restrictions on age, region, or gender.
Studies reported only as conference abstracts will be
included, only if we do not have access to the full paper.
Conference abstracts are often left out of systematic re-
views as they may not contain adequate information to
conduct quality assessment or a meta-analysis. Here, we
will include conference abstracts as they are often pub-
lished earlier than full manuscripts [22], which is key to
a thorough scoping review on an ongoing phenomenon.
Exclusion criteria
Commentaries, correspondences, case reports, case
series, editorials, and opinion pieces will be excluded.
Case reports and case series often contain relatively lim-
ited evidence [23].
Governmental or other agency guidelines will be
excluded.
Reviews such as systematic reviews and scoping re-
views will be excluded, but we will review the references
in these for inclusion, if applicable.
Screening and selection procedure
All reports identified from the searches will be screened
by two reviewers independently. First, titles and abstracts
of articles returned from initial searches will be screened
based on the eligibility criteria outlined above. Second,
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full texts will be examined in detail and screened for eli-
gibility. Third, references of all considered articles will
be hand-searched to identify any relevant report missed
in the search strategy. Any disagreements will be re-
solved by discussion, or if necessary, with a third re-
viewer. A flow chart showing details of studies included
and excluded at each stage of the study selection process
will be provided. We will contact the authors where ne-
cessary if the abstracts do not provide sufficient informa-
tion [22]. Covidence will be used to manage the title/
abstract and full-text screening phases [24].
Data extraction
Reviewers will undergo practice exercises till they have a
high level of agreement (> 0.8 kappa) and then inde-
pendently extract data from studies. Reviewers will ab-
stract the data using a pretested data extraction
template. We will use a standardized coding protocol to
collect information such as title of study, authors, date
published, author affiliation as a measure to ascertain
the discipline focus of the study and collaborating insti-
tutions, study setting, study design, description of meth-
odology, description of the study sample, definition or
type of sexual health studied (if any), measurements and
scales used, main findings, funder information, journal
title, and submission variant (research letter, short re-
port, original article, etc.). Even though a formal risk of
bias is not planned for this scoping review, we will note
which studies are pre-prints, and thus, have not been
formally peer-reviewed.
Data synthesis
Outcomes and other information collected regarding se-
lected studies will be synthesized using quantitative (e.g.,
frequencies) and qualitative (e.g., content and thematic
analysis) methods, with a narrative summary of findings
conducted. The synthesis will be presented in tables,
summary data in graphs, and individual data for each
study in tables. The broad goal of the synthesis is to
identify the gaps in research and present recommenda-
tions for future research agendas.
Discussion
The strength of the planned scoping review is the use of
a transparent and reproducible procedure for a scoping
literature review. We state the data sources, search strat-
egy, and data extraction [25]. Through publishing this
research protocol, we strengthen the clarity of the search
strategy.
There have been few studies which compile available
evidence from various settings in relation to sexual
health and COVID-19. Our review will provide an over-
view of these studies, synthesizing evidence. There is
much anecdotal work around sexual health and COVID-
19, with few published studies. The planned review will
highlight the areas of research focus and gaps which re-
quire more attention. Moreover, the COVID-19 context
is quickly changing [26] likely affecting sexual health in
a rapidly shifting fashion. Results will thus provide high-
level information to inform, support, and customize de-
sign of interventions to mitigate reduced sexual health
outcomes in this setting. As researchers attempt to
minimize the harms from COVID-19, especially for mar-
ginalized populations (e.g., people of color, ethnic mi-
nority groups, women, and sexual and gender minority
populations), they need to be aware of scientific evidence
to develop interventions to achieve their aim. The
planned scoping review seeks to provide this evidence by
contributing an evaluation of what is currently known
about sexual health in relation to COVID-19, with the
goal of identifying gaps in research and presenting rec-
ommendations for future research foci.
Any amendments to this protocol will be documented
in the final published scoping review with reference to
saved searches and analysis.
Results of the review will be disseminated in a peer-
reviewed journal and likely in other media such as con-
ferences, seminars, and symposia. The protocol and final
review article will be made open access upon publica-
tion. As per PRISMA-ScR guidelines, we will present re-
sults in a user-friendly format [27].
Limitations
Our planned review should be read in line with some
limitations. Although we plan to search several databases
and gray literature sources, we may miss some studies.
Not all authors we reach out to may respond, and we
may thus miss some unpublished work. We may not be
able to make policy recommendations due to the lack of
quality appraisal of studies [28].
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s13643-021-01591-y.
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